Pulse Biosciences Inc (PLSE) — Cash Flow-to-Debt Ratio
Latest as of June 2026:
-1.16x
Pulse Biosciences Inc (PLSE) has a Cash Flow-to-Debt Ratio of -1.16x as of June 2026, meaning its operating cash flow of $-18.71 Million could theoretically repay -1% of its total liabilities ($16.06 Million) in one year. See Pulse Biosciences Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-1.16x
Operating CF / Total Liabilities
Operating Cash Flow
$-18.71 Million
USD
Total Liabilities
$16.06 Million
USD
Data as of
Jun 2026
Most recent filing
Pulse Biosciences Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Pulse Biosciences Inc across 12 annual periods. For the full cash flow conversion analysis, see Pulse Biosciences Inc (PLSE) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Pulse Biosciences Inc (2014–2025)
Year-by-year debt coverage analysis for Pulse Biosciences Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.50x | $-54.12 Million | $15.46 Million | ▼ -69.5% |
| 2024 | -2.07x | $-36.34 Million | $17.60 Million | ▲ +7.5% |
| 2023 | -2.23x | $-33.04 Million | $14.79 Million | ▼ -280.6% |
| 2022 | -0.59x | $-47.01 Million | $80.12 Million | ▲ +79.9% |
| 2021 | -2.91x | $-54.10 Million | $18.56 Million | ▼ -51.6% |
| 2020 | -1.92x | $-35.37 Million | $18.40 Million | ▲ +37.1% |
| 2019 | -3.06x | $-34.19 Million | $11.18 Million | ▲ +44.9% |
| 2018 | -5.55x | $-23.90 Million | $4.31 Million | ▼ -91.5% |
| 2017 | -2.90x | $-11.09 Million | $3.83 Million | ▲ +63.4% |
| 2016 | -7.92x | $-8.05 Million | $1.02 Million | ▼ -57.6% |
| 2015 | -5.03x | $-3.32 Million | $659.76K | ▼ -5188.7% |
| 2014 | -0.10x | $-173.14K | $1.82 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.